Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ASXC | Common Stock | Purchase | $5.08K | +18.1K | +86.35% | $0.28 | 39.1K | Dec 14, 2023 | By Trust | F1 |
transaction | ASXC | Common Stock | Sale | -$5.08K | -18.1K | -100% | $0.28 | 0 | Dec 14, 2023 | By Synecor LLC | F1 |
holding | ASXC | Common Stock | 13.8K | Dec 14, 2023 | Direct |
Id | Content |
---|---|
F1 | Synecor LLC, the registered owner of the shares, is dissolving effective December 31, 2023. William Starling, the trustee of the Buyer, is the CEO of Synecor LLC and is an independent director of Asensus Surgical, Inc. A trust of which William Starling is a trustee and settlor bought the shares of Asensus Surgical, Inc. from Synecor LLC for the closing price on the date of purchase. |